Skip to search formSkip to main contentSkip to account menu

12 HR Treprostinil 2.5 MG Extended Release Oral Tablet

Known as: treprostinil 2.5 MG 12HR Extended Release Oral Tablet, TREPROSTINIL DIOLAMINE 2.5MG SA TAB, TREPROSTINIL DIOLAMINE 2.5MG TAB,SA [VA Product] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Pulmonary fibrosis is a progressive disease characterized by disruption of lung architecture and deregulation of the pulmonary… 
2016
2016
Severe Raynaud's syndrome and DUs are the most prevalent manifestations of SSc peripheral microvascular disease. We tested… 
Review
2015
Review
2015
Idiopathic pulmonary arterial hypertension (PAH) is a progressive disease without identifiable etiology and is characterized by… 
2013
2013
IntroductionTreprostinil diethanolamine is an innovative salt form of the prostacyclin analogue, treprostinil sodium, developed… 
2013
2013
BACKGROUND The Tyvaso Inhalation System is a hand-held nebulizer system used to administer treprostinil, an approved therapy for… 
Review
2012
Review
2012
Pulmonary arterial hypertension (PAH) is a life-threatening disease which, if untreated, leads to right ventricular failure and… 
Review
2008
Review
2008
  • 2008
  • Corpus ID: 195105008